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anuric. A renal biopsy was performed after four days. It disclosed
extracapillary glomerulonephritis, with crescents, which destroyed
all glomeruli. Immunofluorescence showed, in addition to heavy
fibrinogen fixation on crescents, linear lgG deposits on glomerular
basement membrane. Four consecutive lupus erythematosus (LE)
cell preparations were positive. Antinuclear antibodies were
1/2048. Anti-DNA antibodies were 102 U/mI by radioimmuno-
logic detection. Antigen antibody complexes were detected by
the labelled Clq technique. Anti-GBM antibodies were dis-
closed by radioimmunologic assay. They had a high affinity for
GBM antigens. The evolution followed a rapidly fatal course, in
spite of hemodialysis treatment, heparin, corticosteroid and cy-
clophosphamide therapy. No extrarenal signs or symptoms were
noted. This case stresses the complexity of pathophysiologic mech-
anisms of human glomerulonephritis.
Experimental cystinuria-dibasic aminoaciduria: Implication for
testing anticystinuric drugs. J. Thomas, C. Charpen tier, E. Thomas
and A. Lemonnier. Unite 17 de I'INSERM (Pr. A. Monsaingeon).
Hbpital Paul Brousse, Villejuif, Laboratoire Central de Biochimie
(Pr. A. Lemonnier), Centre hospitalier de Bicètre, Le Kremlin-Bi-
cètre. Intraperitoneal injection, in the rat, of three dibasic amino
acids—lysine, arginine or ornithine, 2,000 or 3,000 mg/kg of body
wt—provoked a pathological elimination of cystine and of the
three dibasic amino acids, moreover mixed disulfur of cysteine and
homocysteine. This reproduced exactly the profile of human path-
ological cystinuria. This provoked cystinuria allows trial of an-
ticystinuric drugs; u-penicillamine, cs-mercaptopropionylglycine,
sodium dithiosalicylate, well-known for their anticystinuric activ-
ity in man, were administered by i.p. injection, 150 mg/kg of body
wt, 30 mm before arginine injection (3,000 mg/kg of body wt): they
considerably decreased cystine elimination. This method permitted
us to find a similar action for the his (hydroxy-2-ethylthio)-l-l0
decane. Ingestion of that drug by cystinuric patients confirmed the
results obtained in the rat.
Study of plasma refill activity, based on results obtained from 40
patients subjected to intermittent hemodialysis. J. C. Valdenaire, C.
Martineaux, N. de Talence and M. Kessler. Services de Néphrologie
(Pr CI. Huriet) et d'Exploraloins fonctionnelles rena/es et métabo-
liques (Pr M. Boulange) du C.H. U. de Nancy, France. This study is
based on biological assays of plasma renin activity (PRA) in 40
cases of chronic renal failure treated by intermittent hemodialysis
between 1972 and 1974. The authors have distinguished three
clinical groups of patients: 1) patients with normal blood pressure
whose PRA was found to be normal, II) patients whos blood
pressure was normalized by hemodialysis and whose PRA was
found to be higher than in group I and III) patients with malignant
arterial hypertension whose PRA was found to be significantly
higher than in the other two groups (P < 0.001). The 40 subjects
were also studied to determine the effect on PRA of one hemo-
dialysis run: a statistically significant increase was observed in the
case of patients in groups I and II. However, no variation was
noticed in the case of patients in group III. In the case of 18
patients, repeated assays were carried out, but in two cases only
was there evidence of an aggravation in the malignancy of the
hypertension, with an increase in PRA, despite the use of intensive
ultrafiltration. In II of the cases in group III, binephrectomy was
undertaken with positive results in 8 cases.
Hemodynamics and water and sodium excretion in the blood-
perfused isolated dog kidney: Effects of some prostaglandin-synthe-
tase inhibitors. J. L. Vanherweghem, J. Ducobu, A. D'Hollander and
C. Toussaini. Laboratoire de Médecine Experimentale, Université
Libre de Bruxe/les, Fondation Médicale Reine Elisabeth, Bruxelles,
Belgium. In the course of their perfusion with fresh heparinized
blood, dog kidneys demonstrate progressive vasodilation (VD)
with enhanced sodium (CNn) and free water (CHo) clearances. As
these changes could be explained by the action of endogenous
prostaglandins (PG), various PG-synthetase inhibitors were added
to the 400 ml of blood perfusing one kidney, the contralateral
organ serving as control, both kidneys being simultaneously per-
fused on two Nizet's pump-oxygenators. The PG-synthetase inhib-
itors tested were indomethacine (8 mg), naproxen (100 mg), lysine
acetylsalicylate (LAS: 450 mg) and clopirac (100 mg). All com-
pounds regularly inhibited VD, without affecting GFR. They also
increased CN and decreased C0/V (an index of Na reabsorption
in the ascending limb of Henle's loop) without affecting (CNn +
C0)/GFR (an index of the amount of filtered load of solutes
which escaped proximal reabsorption). This latter ratio was, how-
ever, increased by larger LAS dosages (900mg). Intrarenal circula-
tion was analyzed by 141Ce and 85Sr microspheres in the course of
the clopirac experiments. Blood flow in control kidneys steadily
increased within outer (OC) as well as in inner cortex (IC), the
intrarenal partition of both flows, initially favoring IC in com-
parison with kidneys in situ remaining unaffected in the course of
perfusion (OC, 65%; IC, 35%). Clopirac reduced both OC and IC,
the decrement being somewhat larger for IC (OC. 75%; IC, 25%). It
is concluded that VD observed in the isolated kidney, which favors
IC, is prevented by PG-synthetase inhibitors. Paradoxically, these
drugs produce an important increase in Na excretion rate through
inhibiting Na transport in Henle's loop and, at high dosages, in
proximal tubule. This effect could be secondary to a direct tubular
action, common to all four compounds, or would necessitate a




Evidence for a viral etiology in endemic (Balkan) nephropathy.
K. Apostolov and P. Spasic, Hammersmith Hospital, London, Eng-
land. Renal biopsy specimens taken at operation from seven
patients with clinically typical endemic (Balkan) nephropathy have
been examined by thin sectioning and electron microscopy. The
glomeruli showed mesangial changes, and the basement membrane
was grossly thickened and convoluted. The renal tubules showed
evidence of cell fusion and spongiform degeneration. Numerous
cytoplasmic vesicles containing both free and apparently budding
particles of size 80 to 200 nm were found. These particles bore the
appearance of a coronavirus as seen by thin sectioning, and were
similar in appearance to those seen in the kidneys of chickens
infected with infectious bronchitis virus of fowls, which is also a
coronavirus. It is suggested that the disease is, in fact, a slow virus
infection of the kidney by a coronavirus, and data will be presented
which suggest that the pig may be the primary source of infection.
Irreversible structural changes in intrarenal vessels associated with
pregnancy: A clinical, histologic and angiographic study. R. P. Bur-
den, W. N. Boyd, K. Baker, M. 0. Grant, T. H. Marshall andG. M.
Aber. Department of Nephrology, North Staffordshire Royal In-
firmary. Hartshill, Stoke-on-Trent, England. The effect of certain
complications of pregnancy (including preeclampsia and abruptio
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placenta) on the histologic and angiographic appearances of the
intrarenal vessels and on blood pressure and renal function have
been studied in 20 patients in whom there was no evidence of
preexisting hypertension or renal disease. Three months after the
acute episode, all patients had angiographic abnormalities which
included tortuosity, occlusions, irregularity of the lumen and stasis
of contrast involving the interlobar and arcuate arteries. In the
nephrogram there was evidence of peripheral ischemia, loss of the
normal demarcation between cortex and medulla and cortical in-
farcts. Histologic abnormalities of the vessels were confined to
thrombi in glomerular capillaries in two patients, and to reduplica-
tion of the internal elastic lamina in a third. At the time of the renal
angiography and biopsy, 33% of patients had impairment of creati-
nine clearance and 25% were hypertensive (diastolic blood pres-
sure, 90 mm Hg or more). Patients were followed for periods of up
to five years (mean, three years) and during this time there was no
further deterioration in renal function although 50% of the total
had become hypertensive. Although the severity of the abnor-
malities of the intrarenal circulation bore a close relationship to the
degree of microangiopathy which occurred during the acute obstet-
ric complication, i.e., being more severe in patients with abruptio
placenta, established hypertension was less common in this group.
Prognosis, disease activity and immunologic tests in lupus ne-
phritis. J. S. Cameron, N. G. P. Slater, D, R. Turner, B. D. Williams
C. S. Ogg, D. G. Williams and M. H. Lessof Departments of
Medicine and Pathology, Guys Hospital, London, England. A num-
ber of tests have been suggested to be useful predictors of outcome
in lupus nephritis. These include the appearance of renal biopsy
specimens, serum complement concentrations and a variety of tests
based upon the presence, quantity or quality of circulating an-
tibody against native double-stranded DNA. We have studied sera
from 99 patients with clinical evidence of lupus nephritis, of whom
65 had a renal biopsy. Data from SI biopsied patients with at least
one year's follow-up have been analyzed in detail. Serial com-
plement (C3 and C4) concentrations have been accumulated and
DS-DNA binding has been measured by the Farr method. Both
the counter-immunoelectrophoresis test for precipitating DNA an-
tibody and the recently described Crithidia luciliae kinetoplast
assay have also been examined retrospectively. The clinical activity
at each attendance or admission was evaluated serially at nearly
300 points in 32 of the biopsied patients with two years' follow-up
using a seven-point scale. At onset, the best predictor of outcome is
the appearance of the renal biopsy specimen; although evolution
from mild appearances to severe nephritis has been observed in five
individuals, and some patients with severe histologic appearances
have done well. Although the DNA binding and kinetoplast assays
had high diagnostic precision, neither the degree of DS-DNA bind-
ing nor the kinetoplast titer correlated well with clinical activity (of
renal disease) in the majority of patients. Correlation between C4
concentrations and activity was better. Correlation between C3
and C4 and DNA binding or kinetoplast titers were also poor.
Suppression of immunologic activity, as judged by these tests, may
be both unnecessary and dangerous in some patients; clinical and
histologic criteria still remain the best guide for treatment.
Silicon and the kidney. J. W. Dobbie, M. J. B. Gray and A. C.
Kennedy. Tenovus Kidney Diseases Research Unit, and the Univer-
sity Department of Medicine, Royal Infirmary, Glasgow, Scotland.
Suspicion of silicon as a potential nephrotoxic agent in man comes
from its possible role as an etiologic factor in endemic nephropathy
(Marcovic BL, Arambasic MD: J Pathol 103:35, 1971) and from
earlier work on the incidence of renal lesions in silicosis (Saita G,
Zavaglia 0: Med Lay 42:41, 1951; Kolev K, Doitschinov D, Todo-
roy D: Med Lay 61:205, 1970). However, the lack of a simple,
reliable method of measuring silicon in biological fluids has so far
hindered any comprehensive study of silicon metabolism in man.
This paper describes a) the successful application of atomic ab-
sorption spectroscopy to the measurement of urinary silicon; b) the
determination of mean daily excretion of silicon in 45 healthy
young adults (mean, 7.44 mg of Si/24 hr; so, 3.54); c) a significant
rise in urinary excretion of silicon (3- to 38-fold increase) in a
group of 14 young adults following ingestion of 5 g of magnesium
trisilicate B.P.; d) A separate series of investigations in which the
nephrotoxicity of silicon was investigated in the experimental ani-
mal. Three silicon-containing compounds (magnesium trisilicate
B.P., crushed quartz and crushed Arran granite) were added to the
drinking water (250 mg/liter) of three groups of male guinea pigs
for four months. At autopsy, all animals receiving magnesium
trisilicate and two animals receiving crushed quartz showed focal
interstitial nephritis. In view of the increasing exposure of Western
man to silicate food additives, the present findings suggest that the
potential nephrotoxicity of silicon merits further study.
The treatment of the refractory anemia of nephrectomized hemo-
dial ysis patients with cobalt chloride. J. M. Duckham and H. A. Lee.
Wessex Renal Unit, St. Mary's General Hospital. Portsmouth, Eng-
land. Anephric patients on routine maintenance hemodialysis have
received therapeutic trials with small doses of enteric coated cobalt
chloride. Six of eight patients who completed the first trial with
enteric coated cobalt chloride, 50 mg daily for 12 weeks, showed a
significant rise in hemoglobin concentration of over 25% during
therapy and a fall to near pretherapeutic levels when cobalt was
withdrawn. The improvement in hemoglobin concentration was
reproducible and could be maintained with doses of 25 mg of
cobalt chloride daily. With longer periods of treatment, the he-
moglobin concentration could be improved by up to 70%. Four of
the patients showed a definite diminution in their blood trans-
fusion requirements and three experienced a definite sense of in-
creased well-being during treatment. Only one patient was unable
to complete a trial of therapy due to gastrointestinal side effects
and it is possible that one patient developed reversible high tone
hearing loss due to the toxic effects of cobalt after 56 weeks of
treatment. Serum cobalt levels tended to stabilize after two
months' continuous treatment in the therapeutic range of 40 to 100
g/IO0 ml, A rapid fall in serum cobalt was seen on cessation of
treatment. Having gained a good response with cobalt chloride, 50
mg daily for 12 weeks, it is suggested that an intermittent course of
cobalt can be given or the dose can be reduced to a maintenance
dose of 25 mg daily. Using these dose regimes we do not anticipate
unwanted side effects of therapy, particularly as cobalt is dialy-
zable.
Avascular necrosis of bone following renal transplantation. K. M.
Hawking. B. F. van den Bosch and J. M. Wilmink. University
Hospital D(jkzigt, Department of Internal Medicine I and Depart-
ment for Orthopaedic Surgery, Erasmus University (EU), Rotter-
dam; and Department of Medicine, Wilhelmina Gasthuis, Amster-
dam, The Netherlands. Avascular necrosis of bone (AVN) is a
common complication of otherwise successful renal trans-
plantation, occurring in 5 to 37% of recipients in most reported
series. Fifty-five patients received cadaver renal allografts at EU
between May, 1971 and January, 1975. Forty-four of these had
functioning grafts for nine months and longer, 18 of these (4 1%)
developed AVN between 130 and 700 days after transplantation.
Seven patients have needed orthopedic surgery (ten hip replace-
ments, one Marmar knee prothesis and one knee exploration) for
severe pain or disability. At the Renal Transplantation Unit, Wil-
helmina Gasthuis, Amsterdam, the incidence of AVN is lower, and
the disease less severe. Between 1968 and January, 1975 58 patients
received 61 transplants. Forty-one (7 1%) of these had renal func-
tion for more than nine months, and only six of these (15%)
developed AVN. One patient had severe pain and needed ortho-
pedic surgery. Patients, kidneys and doses of prednisone received
were similar at the two centers. Among the recipients at EU, no
differences were found between patients with subsequent AVN and
those without with respect to age or sex of recipient or donor,
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duration of dialysis before or after transplantation, method or
duration of preservation of the donor kidney or amount of pred-
nisone received. Twelve of the 16 patients (75%) living in the
immediate vicinity of Rotterdam developed AVN as compared to
six of 28 (2 1%) living elsewhere. This suggests than an environmen-
tal factor, such as water supply, may be contributing to the high
incidence of AVN at EU.
Plasma-exchange and immunosuppression in the treatment of
Goodpasture's syndrome. C. M. Lockwood, A. J. Rees, Pamela
Ewan, D. K. Peters and C. B. Wilson. Department of Medicine,
Royal Postgraduate Medical School, London, England; and Depart-
ment of Experimental Pathology, Scripps Clinic and Research Foun-
dation, La Jolla, California. Eight patients with Goodpasture's
syndrome, all of whom had demonstrable circulating antibody to
glomerular basement membrane (GBM) as detected by radio-
immunoassay, were treated by a regime of intensive plasma-ex-
change, cytotoxic drugs and steroids. Four patients had some renal
function at presentation and in three of these there was improve-
ment in renal function and termination of anti-GBM antibody
synthesis following this therapeutic regime. The fourth patient, at
present in the second week of treatment, is showing improvement
in renal function and fall in anti-GBM antibody titer. The other
four patients were anuric at presentation and all had extensive
changes on renal biopsy. No return of renal function occurred'in
this group and anti-GBM antibody levels, although reduced by the
combination of plasma-exchange, cytotoxic drugs and steroids,
remained elevated. Pulmonary hemorrhage was a feature at pre-
sentation in six patients and in one was severe and life-threatening.
In this patient and four others, lung bleeding was arrested soon
after the start of therapy. In a further patient, currently undergoing
therapy, hemoptysis has stopped after one week's treatment. The
"deglobulinating" effect of plasma-exchange using purified protein
fraction, leading to depletion of fibrinogen, complement and im-
munoglobulins will be discussed.
Clofibrate-induced muscle damage in patients with chronic renal
failure. A. M. Pierides, F. Alvarez- Ude and D. N. S. Kerr. Depart-
ment of Medicine, University of Newcastle upon Tyne, England.
Four patients in chronic renal failure who were given I to 2 g of
clofibrate daily developed a hypercatabolic state and a clinical
syndrome characterized by widespread muscle weakness and ten-
derness, particularly affecting proximal muscles. Muscle enzymes
such as creatinine kinase rose significantly to up to 8,000 U/liter. Two
patients with advanced but static renal failure (serum creatinine, 9
to 12 mg/l0O ml) deteriorated rapidly with a rise in serum urea and
creatinine and required early dialysis. Renal function did not re-
cover in these two patients when clofibrate was withdrawn and at
present one of the patients continues on regular hemodialysis while
the other patient, who was a poor regular hemodialysis patient,
died a few weeks later. One patient with mild renal failure (serum
creatinine, 3.5 mg/lOO ml) recovered fully when clofibrate was
withdrawn. One anephric patient already on regular hemodialysis
developed the clinical syndrome and also a marked paradoxical
rise in cholesterol and fasting triglycerides up to 3.5 g/lOO ml.
Serum chlorophenoxyisobutyric acid (CPIB), the circulating active
metabolite of clofibrate, was estimated serially in two of the
patients and was found to be markedly elevated, outside the thera-
peutic range. It is thought that high serum levels of this compound
are responsible for the observed side effects. It is suggested that
uremia leads to accumulation of CPIB with a rise in the free
circulating fraction. Under these circumstances, clofibrate should
be used very cautiously indeed, ensuring an appropriate reduction
in dosage according to residual renal function. Regular monitoring
with serum muscle enzymes and CPIB are advisable.
European Dialysis and Transplant Association
Hamburg, Federal Republic of Germany
June 22—25, 1976
Efficacy of petroleum charcoal hemoperfusion and acetate-free
dialysate in eight patients with hepatic coma. I. Amano, H. Kano, S.
Iwatsuki, H. Takahira, K. Ohta and K. Maeda. Chukyo Hospital
and The Biodynamics Research Institute, Nagoya, Japan. Although
the pathogenesis of hepatic coma is complicated, we have tried to
save patients by eliminating encephalogenic substances and cor-
recting electrolytes and pH. Our artificial liver assist is a combina-
tion of petroleum charcoal hemoperfusion and hemoperfusion us-
ing acetate-free dialysate. The feature of petroleum pitch charcoal
is that it releases small amounts of 1.2 to 5.0 t pulverized carbon.
It shows excellent adsorption in vitro for methionine of amino
acids, short chain fatty acid and some annuli amins. Two cases of
eight patients were advanced posthepatic cirrhosis and one of them
had a porta caval shunt. The remaining six cases were fulminant
viral hepatitis. Seven of the eight patients with grade 3 to 4 coma
recovered consciousness and three of them survived. Dialysate was
free of acetate which was affected more by charcoal adsorption
than bicarbonate. Bicarbonate contained in dialysate could correct
pH stabler than acetate. Our experience shows that independently
the charcoal hemoperfusion and the body fluid correction device
cannot be effectively used. Reproduction of liver tissues, in histo-
logical study, was observed in spite of considerable hemoperfusion
as many as ten times. No emboli of pulverized carbon were seen in
the lungs, liver, spleen or kidneys.
A full account of the meeting will appear in the Proceedings of the
EDTA by January 1976. AB Gambro (Sweden) has kindly assisted
with the publication of the abstracts. Only those abstracts that have
been selected for presentation are included.
Accumulation and excretion of middle molecules. H. Asaba. J.
Bergstrom, P. FOrst and L. Zimmerman. Department of Nephrology.
S:i Eriks sjukhus, Stockholm, Sweden. There is evidence that poten-
tially toxic middle molecules (MM) accumulate in uremia, but
little is known about their rate of generation and excretion. By
using gel filtration combined with gradient elution chromatogra-
phy, we evaluated quantitatively the concentration of MM frac-
tions (7a, b, c) from the integrated peak areas of the chromato-
grams. Plasma and urine from patients with varying degrees of
renal failures were analyzed. Among 85 patients studied, measur-
able plasma peaks were only found when serum creatinine was
above 6 mg/l00 ml or creatinine clearance (Kr) below 10 mI/mm.
No correlation was found between serum urea and serum creati-
nine and the accumulation of fraction 7a, bore. There was a linear
correlation between Kcr and the renal clearance of 7a, band c (K7a,
K7b. K7). K?b and K7e were on average equal to Ker; K7a was
higher indicating either some tubular excretion or production by
the kidney. The rates of excretion of individual MM in the urine
varied considerably among different patients; peaks found high in
plasma were also found high in the urine. Taking excretion rate to
be equal to generation rate, the results indicate that great differ-
ences in production (by a factor of 5 or more) are more important
for the accumulation of MM than passive retention. This also
explains the lack of correlation with serum urea and serum creati-
nine. In consequence, mathematical models for calculating the
level of MM based on the assumption of a constant production
rate will give erroneous results.
Wrist watch-size single-needle clamping device. R. A. Baillod, C.
M. Roberts, J. F. Moorhead, Z. Varghese and A. Peacock. Renal
Unit, Royal Free Hospital, London, England. Recent technical ad-
